Remove 2018 Remove Competition Remove Leads
article thumbnail

Pharma is big business whose goal is to maximize shareholder value

World of DTC Marketing

From 2016 to 2020, the 14 leading drug companies spent $577 billion on stock buybacks and dividends—$56 billion more than they spent on R&D over the same period.” One company, Amgen, spent nearly six times as much on buybacks, dividends, and executive compensation as it did on R&D in 2018. Big pharma is big business.

Pharma 292
article thumbnail

Episode 28 – A CEO Leading a MedTech Company Through Covid

Medical Device Success

Reading time: 2 – 3 minutes In January 2018 when Dominik Beck took the helm of Rudolf Riester, GmbH, he began executing a plan to put Riester in a more competitive position against its larger rivals. Then in early 2020 Covid spread across the world. But to take advantage of an opportunity, you have to execute.

Leads 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

8 Ways to Enhance the Patient Experience & Drive Leads with QR Codes

Healthcare Success

Ready to start leveraging QR code technology and stay ahead of your competition? In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. . 8 Ways to Improve the Patient Experience & Drive Leads with QR Codes.

Leads 113
article thumbnail

Our Best of 2018- to Fuel Your Best 2019

Integrity Solutions

Here is some of our ‘Best of 2018’ content that can help fuel thoughts, discussions and strategies to make 2019 your best year yet. They have become increasingly more important- even becoming a competitive differentiator. Our most-read blog of 2018 was this one by Joyce Hames.

article thumbnail

Highly Cited Researchers 2021: How nations and institutions foster exceptional performance

Clarivate

We name 332 researchers on our list at research institutes in Australia this year – an increase in share to 5% (from 4% in 2018). The university has also invested in the recruitment of top researchers from around the world to lead research programs and mentor young up-and-coming researchers.

article thumbnail

Digital transformation to drive biomanufacturing market

European Pharmaceutical Review

Influencing factors identified in the report include higher competition, competitive pricing and inflation rate, technological advancements and evolving regulatory guidelines. These factors have led to industry 4.0 technologies.

Marketing 105
article thumbnail

The EU HTA regulation: a new frontier for access to innovative technologies

European Pharmaceutical Review

1 The regulation is the culmination of a long debate between European Union (EU) Member States and health sector stakeholders, triggered by joint actions such as European Network for Health Technology Assessment (EUnetHTA) and formalised through the European Commission (EC)’s proposal in January 2018. It introduces an evidence? References.